Hypercoagulability has emerged as a prominent consequence of COVID-19. This presents
challenges not only in the clinic, but also in thrombosis research. Health and safety …

As of 26 July 2023, the SARS-CoV-2 virus has caused 768,560,727 confirmed cases of the
Coronavirus disease 2019 (COVID-19), and 6,952,522 fatalities worldwide [1]. Although the …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first
reported in Wuhan, China in December 2019, moved across the globe at an unprecedented …

The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent
history of humankind, afflicting more than 27 million individuals to date. While the majority of …

Limited knowledge is available on the relationship between antigen-specific immune
responses and COVID-19 disease severity. We completed a combined examination of all …

The novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total …

Bearing a strong resemblance to the phenotypic and functional remodeling of the immune
system that occurs during aging (termed immunesenescence), the immune response to …

Abstract SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19
(COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over …

Introduction both symptomatic and asymptomatic SARS-CoV-2 infections–coined
Coronavirus disease 2019 (COVID-19)–have been linked to a higher risk of cardiovascular …

Since the first reported cases with severe acute respiratory syndrome caused by a novel
coronavirus (SARS-CoV2), this disease called coronavirus disease (COVID-19) has …